Webcasts/ IR Events
Request for Information
SOMX (Common Stock)
3:59 PM ET | 03/06/2013
Delayed at least 20 min., by eSignal.
Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products for the treatment of diseases and disorders in the central nervous system therapeutic area. Somaxon's lead product candidate is Silenor® (doxepin) for the treatment of insomnia.
More Press Releases » Latest News